BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
T cell receptor signaling pathway
,
Influenza
,
Breast
,
Laryngoscope
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hENT1
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle…
PPARĪ± and PPARĪ³ regulate the nucleoside transporter hENT1.
Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cel…
New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal tr…
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patie…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining
A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine …
RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as P…
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancrea…
A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in P…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ